Search results
Novavax awaits FDA decision on whether its next COVID shot can be offered in US
Reuters via AOL· 20 hours agoNovavax will only be able to offer a COVID-19 vaccine in the United States this autumn if regulators...
Why Novavax (NVAX) Stock Price Appreciated 14% on Monday
Zacks via Yahoo Finance· 4 days agoNovavax (NVAX) surges after one of its top shareholders drops a proxy campaign against the company....
Novavax (NASDAQ:NVAX) Trading 3.4% Higher
ETF DAILY NEWS· 1 day agoNovavax, Inc. (NASDAQ:NVAX – Get Free Report) shot up 3.4% during trading on Wednesday . 1,132,956 shares changed hands during trading, a decline of 90% from the average session ...
3 Things You Need to Know If You Buy Novavax Today | The Motley Fool
The Motley Fool· 3 days agoNovavax (NVAX 5.30%) stock has both soared and plummeted at times in recent years. Investors...
COVID’s New ‘FLiRT’ Variants—What To Know As Experts Fear Summer Surge
Forbes· 3 days agoNew coronavirus variants dubbed “FLiRT” are circulating the world and growing dominant in the U.S.,...
Better Buy: Inovio Pharmaceuticals vs. Novavax
The Motley Fool via AOL· 3 days agoThe COVID-19 vaccine was worth tens of billions of dollars, but most of it went into the hands of Moderna and Pfizer. Smaller biotechs that tried to...
Why Vaccine Stocks Rallied This Week
The Motley Fool via AOL· 1 day agoShares of vaccine stocks Moderna (NASDAQ: MRNA), Novavax (NASDAQ: NVAX), and BioNTech SE (NASDAQ: BNTX) rallied this week, appreciating 23.4%, 16.4%, and...
Novavax, Inc. (NASDAQ:NVAX) Given Average Recommendation of “Hold” by Brokerages
ETF DAILY NEWS· 6 days agoNovavax, Inc. (NASDAQ:NVAX – Get Free Report) has been given an average recommendation of “Hold” by the five analysts that are presently covering the firm, Marketbeat.com ...
JP Morgan Upgrades Novavax, Inc. (NVAX) to a Neutral from an Underweight – Knox Daily
Knox Daily· 5 days agoNovavax, Inc.’s recently made public that its President, R&D Dubovsky Filip unloaded Company’s shares for reported $0.66 million on May 14 ’24. In the deal valued at $13.90 ...
Novavax investor drops proxy battle in wake of big pharma deal - Washington Business Journal
The Business Journals· 5 days agoA Novavax Inc. shareholder that had been waging a campaign to oust three board members has withdrawn...